en · de · es · fr · pt
cardarine-notes.peptides9000.com › Blog › Regulation And Analytical Detection — Reference Sheet

Regulation And Analytical Detection — Reference Sheet

By Editorial Desk · published 2025-12-10 · last reviewed 2026-01-04 · Blog

This is a working overview of Nuclear receptor, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-01-04 and is reviewed periodically as new material appears.

Regulation and Analytical Detection

Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.

Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.

Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.

Background and Regulatory History

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Cardarine at a glance

PropertyValueNotes
Regulatory statusProhibited in sportListed by WADA as a metabolic modulator.
Approved medical useNone in major jurisdictionsNot a registered drug.
Common test matrixUrineMost anti-doping samples use urine.
Typical detection methodLC-MS/MSDetects parent compound and metabolites.
Reference standard storage-20 °C, desiccatedTypical for analytical standards.

Cardarine as Investigational PPARδ Agonist

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.

Related pages on this site

Regulation and Detection

Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.

Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.

Identity and Pharmacological Classification

Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.

PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.

Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.

Supporting material

In the absence of albinism or hyperpigmentation, the human epidermis contains approximately 74% eumelanin and 26% pheomelanin, largely irrespective of skin tone, with eumelanin content ranging between 71.8–78.9%, and pheomelanin varying between 21.1–28.2%. Total melanin content in the epidermis ranges from around 0 μg/mg in albino epidermal tissue to >10 μg/mg in darker tissue. In the human skin, melanogenesis is initiated by exposure to UV radiation, causing the skin to darken. Eumelanin is an effective absorbent of light; the pigment is able to dissipate over 99.9% of absorbed UV radiation. Because of this property, eumelanin is thought to protect skin cells from UVA and UVB radiation damage, reducing the risk of folate depletion and dermal degradation. Exposure to UV radiation is associated with increased risk of melanoma, a cancer of melanocytes (melanin cells). Studies have shown a lower incidence for skin cancer in individuals with more concentrated melanin, i.e. darker skin tone.

Type I-minus is capable of manipulating objects on the scale of itself: building structures, mining, joining and breaking solids; Type II-minus is capable of manipulating genes and altering the development of living things, transplanting or replacing parts of themselves, reading and manipulating their genetic code; Type III-minus is capable of manipulating molecules and molecular bonds, creating new materials; Type IV-minus is capable of manipulating individual atoms, creating nanotechnology at the atomic level, and creating complex forms of artificial life; Type V-minus is capable of manipulating the atomic nucleus and engineering the nucleons that compose it; Type VI-minus is capable of manipulating the most elementary particles of matter (quarks and leptons) to create organized complexity among populations of elementary particles; Type Omega-minus is capable of manipulating the fundamental structure of space and time. In Impossibility: The Limits of Science and the Science of Limits (1998), Barrow proposes a scale ranging from "BI" to "BVI", with an ultimate stage he calls "BΩ", the former characterized by the possibility of manipulating one's environment, while the latter allows for the modification of spacetime.

== Uses == The useful physiological properties of yeast have led to their use in the field of biotechnology. Fermentation of sugars by yeast is the oldest and largest application of this technology. Many types of yeasts are used for making many foods: baker's yeast in bread production, brewer's yeast in beer fermentation, and yeast in wine fermentation and for xylitol production. So-called red rice yeast is actually a mold, Monascus purpureus. Yeasts include some of the most widely used model organisms for genetics and cell biology.

The cattle boats were examined, but the dates of the murders did not coincide with a single boat's movements, and the transfer of a crewman between boats was also ruled out. At the end of October, Robert Anderson asked police surgeon Thomas Bond to give his opinion on the extent of the murderer's surgical skill and knowledge. The opinion offered by Bond on the character of the "Whitechapel murderer" is the earliest surviving offender profile. Bond's assessment was based on his own examination of the most extensively mutilated victim and the post mortem notes from the four previous canonical murders. In his opinion the killer must have been a man of solitary habits, subject to "periodical attacks of homicidal and erotic mania", with the character of the mutilations possibly indicating "satyriasis". Bond also stated that "the homicidal impulse may have developed from a revengeful or brooding condition of the mind, or that religious mania may have been the original disease but I do not think either hypothesis is likely".

== Reception == Even prior to its publication people drew comparisons to The Hunger Games, Harry Potter or the Twilight series. Half Bad has also been compared to Nineteen Eighty-Four by George Orwell. It had already broken two Guinness World Records as the most translated book – and the most translated children's book – by a debut author before publication. A Publishers Weekly starred review states, "This grim and thrilling tale, first in a planned trilogy, features understated prose that lets readers' imaginations fill in the blanks, as well as a well-developed sense of Witch culture. Nathan, the damaged survivor of horrific abuse, is an unforgettable protagonist, and Green expertly captures his torment at being caught between the mutually hostile sides of his heritage." Kirkus Reviews states, "Green propels Nathan forward with the help of often underdeveloped secondary characters, who are overshadowed by the imaginary relationship Nathan builds with his father; it is this that keeps both Nathan and readers going." In a review for Tor.com, Kat Kennedy writes, "Sally Green's Half Bad is the perfect novel for inspiring one to despise all of humanity or fall onto the ground and weep pathetically. Needless to say, it is an excellent book." In a review for The Guardian, Philip Womack writes, "While there is nothing new here, Half Bad's combination of themes will no doubt be entirely attractive to a large section of readers.

Sources: en.wikipedia.org

Notes from published material

== Interactions == Sauvagine has been shown to interact with corticotropin releasing factor receptors 1 and 2, and (as with other CRF-related peptides) is also bound by the corticotropin-releasing factor binding protein.

Pevehouse, Jon C. W., Timothy Nordstron, Roseanne W. McManus, Anne Spencer Jamison (2020). "Tracking Organizations in the World: The Correlates of War IGO Version 3.0 datasets." Journal of Peace Research, 57(3), 492–503. https://www.jstor.org/stable/48596260. Roger, Charles, Sam Rowan, "The New Terrain of Global Governance: Mapping Membership in Informal International Organizations", Journal of Conflict Resolution, 67 (6): 281–310. Lundgren, Magnus, Theresa Squatrito, Thomas Sommerer, Jonas Tallberg (2023). "Introducing the Intergovernmental Policy Output Dataset (IPOD)". The Review of International Organizations 19, 117–146 (2024). https://doi.org/10.1007/s11558-023-09492-6. Eilstrup-Sangiovanni, Mette (March 2021). "What kills international organisations? When and why international organisations terminate". European Journal of International Relations. 27 (1).

=== Issues with theories === No single type of theory is satisfactory on its own; social cognition theories poorly address autism's rigid and repetitive behaviors, while most of the nonsocial theories have difficulty explaining autism's social impairment and communication difficulties. A combined theory based on multiple deficits may prove to be more useful.

== Biosynthesis == PPG is produced by enzymes of two gene clusters. Recent work on the peptide ligases show, surprisingly, a common origin with murein synthesis. The pathway is now known to include the orthologous-to-bacteria CarB, MurC/D (peptide ligase), MurG, MraY, UppP, UppS, and flippase presumably performing an analogous function, and two novel but conserved transmembrane proteins. GlmM and GlmU, which produce UDP-GlcNAc in bacteria, are also present with phosphoglucomutase (PGM). Half of the species also have MurT and GatD, known to perform cell wall modifications in bacteria. No orthologous cross-linking enzymes have been identified. Notably, "formation of the disaccharide moiety of the glycopeptide monomer occurs before the transfer to membrane protein by MraY", as opposed to after in bacteria. Further work would be needed to connect these information into a coherent pathway.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine legal to buy?

Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.

How is cardarine detected in athletes?

Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.

Does cardarine have approved medical uses?

No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Network